Advertisement
Singapore markets closed

  • Straits Times Index

    3,292.69
    +10.64 (+0.32%)
     

  • Nikkei

    38,405.66
    +470.90 (+1.24%)
     

  • Hang Seng

    17,763.03
    +16.12 (+0.09%)
     

  • FTSE 100

    8,144.13
    -2.90 (-0.04%)
     

  • Bitcoin USD

    62,955.66
    -677.18 (-1.06%)
     

  • CMC Crypto 200

    1,289.85
    -49.22 (-3.68%)
     

  • S&P 500

    5,074.28
    -41.89 (-0.82%)
     

  • Dow

    38,021.51
    -364.58 (-0.95%)
     

  • Nasdaq

    15,817.65
    -165.44 (-1.04%)
     

  • Gold

    2,308.30
    -49.40 (-2.10%)
     

  • Crude Oil

    81.91
    -0.72 (-0.87%)
     

  • 10-Yr Bond

    4.6630
    +0.0490 (+1.06%)
     

  • FTSE Bursa Malaysia

    1,575.97
    -6.69 (-0.42%)
     

  • Jakarta Composite Index

    7,234.20
    +78.41 (+1.10%)
     

  • PSE Index

    6,700.49
    -69.15 (-1.02%)
     

Should You Invest in Tandem Diabetes Care (TNDM)?

Soumya Eswaran
·2-min read

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds released “The RiverPark/Next Century Growth Fund” Q4 2023 investor letter in partnership with Next Century Growth Investors, LLC. A copy of the same can be downloaded here. The fund returned 4.75% in the fourth quarter compared to a 12.75% return for the Russell 2000 Growth Total Return Index. The recent market rally highlights the significance of macroeconomic indicators and the Fed's stance on interest rates. In addition, please check the fund’s top five holdings to know its best picks in 2023.

The RiverPark/Next Century Growth Fund featured stocks like Tandem Diabetes Care, Inc. (NASDAQ:TNDM) in the fourth quarter 2023 investor letter. Headquartered in San Diego, California, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is a medical device company. On April 4, 2024, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) stock closed at $33.17 per share. One-month return of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) was 8.05%, and its shares lost 19.98% of their value over the last 52 weeks. Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has a market capitalization of $2.177 billion.

The RiverPark/Next Century Growth Fund stated the following regarding Tandem Diabetes Care, Inc. (NASDAQ:TNDM) in its fourth quarter 2023 investor letter:

"Tandem Diabetes Care, Inc. (NASDAQ:TNDM) offers a next-generation insulin pump for patients with diabetes. TNDM is a company we have owned in the past but sold as they went through a period of slowing growth rates due to a lack of product innovation. With 4 new product launches expected in 2024, the stage is set for a reacceleration of growth in this large and growing end market. With expectations low and valuation depressed from historical averages, there is room for upside if TNDM can deliver on their 2024 guidance and the new products rollout as expected."

A hospital room with a patient using a medical device to administer insulin. Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is not on our list of 30 Most Popular Stocks Among Hedge Funds. At the end of the fourth quarter, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) was held by 24 hedge fund portfolios, compared to 17 in the previous quarter, according to our database. We discussed Tandem Diabetes Care, Inc. (NASDAQ:TNDM) in another article and shared the list of best diabetes stocks to buy. In addition, please check out our hedge fund investor letters Q4 2023 page for more investor letters from hedge funds and other leading investors.

ADVERTISEMENT

Suggested Articles:

Disclosure: None. This article is originally published at Insider Monkey.